Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 88Leukemia 45Lymphoma, Extranodal NK-T-Cell 24Burkitt Lymphoma 19Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 12Lymphoma 12Recurrence 9Leukemia, Biphenotypic, Acute 9Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 6Lymphohistiocytosis, Hemophagocytic 5Leukemia, T-Cell 4Neoplasms 3Lymphoma, T-Cell 3Leukemia, Myeloid, Acute 3Down Syndrome 3Lymphoma, Non-Hodgkin 2Epstein-Barr Virus Infections 2Ovarian Neoplasms 1Neoplasms, Plasma Cell 1Neoplasm, Residual 1Multiple Myeloma 1Mucositis 1Lymphoproliferative Disorders 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphoid 1Leukemia, B-Cell 1Immunoproliferative Disorders 1Hodgkin Disease 1Hematologic Neoplasms 1Fallopian Tube Neoplasms 1

Interventions

Cyclophosphamide 22blinatumomab 18Cytarabine 15fludarabine 13Azacitidine 12venetoclax 10fludarabine phosphate 10Rituximab 8Lenalidomide 7Dexamethasone 7Methotrexate 6Daunorubicin 6Mercaptopurine 5daratumumab 4Whole-Body Irradiation 4Vincristine 4Melphalan 4Idarubicin 4Etoposide 4Busulfan 4pembrolizumab 3obinutuzumab 3Radiotherapy 3Maintenance 3Immunotherapy, Adoptive 3Imatinib Mesylate 3Granulocyte Colony-Stimulating Factor 3Drug Therapy 3Cladribine 3Asparaginase 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Neoplasm, Residual × pegaspargase × Clear all
NCT00198991 2022-08-18

German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003)

Goethe University

Phase 4 Completed
1,883 enrolled
LymphoidOther hematologic neoplasm

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡